Testing a diabetes pill under the tongue for type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This early-phase study tests the safety and side effects of liraglutide taken under the tongue, and looks for early signs it improves blood sugar in people with type 2 diabetes. It may help people who want an alternative way to get this medication, but the main goal is to see how safe and tolerable it is.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 to 65 years old
- Have type 2 diabetes for at least 1 year
- Have body weight in a BMI range of 18 to 35
- Have blood sugar and diabetes test results in these ranges (HbA1c 6.5% to 9.0%)
- Be on a stable diabetes plan: usually stable metformin for at least 2 months, or diet/exercise only with stable HbA1c
- Have heart tests and blood pressure that are within allowed limits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a new medicine (elecoglipron) combined with dapagliflozin is safe and works better for adults with type 2 diabetes that isn't well controlled by diet or other medications.
This study tests a new medication called bofanglutide in adults with type 2 diabetes who are currently taking metformin. The medication works similarly to a hormone that helps control blood sugar, and the study aims to see if it can help lower blood sugar levels and manage weight better.
This study tests how well a new combination diabetes medication (chiglitazar/metformin) works in the body compared to taking the two drugs separately. It is for healthy volunteers and helps ensure the new pill is safe and effective.
This study tests a new pill called HDM1002 for adults with type 2 diabetes. It aims to see if it helps control blood sugar when added to your current metformin treatment.
This trial tests a new combination pen (insulin degludec with liraglutide) for people with type 2 diabetes whose blood sugar is not well controlled on metformin alone or with one other pill. The goal is to see if the combination improves blood sugar control safely.
This study tests a new once-every-2-weeks pill (cofrogliptin) added to your current diabetes medications (metformin and dapagliflozin) compared to a daily pill (linagliptin). It may help improve blood sugar control with fewer daily pills.
Hear when a new Diabete Type 2 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.